The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
RNA-Guided Human Genome Engineering via Cas9
Open accessAbstract
Genome Editing: Clustered regularly interspaced short palindromic repeats (CRISPR) function as part of an adaptive immune system in a range of prokaryotes: Invading phage and plasmid DNA is targeted for cleavage by complementary CRISPR RNAs (crRNAs) bound to a CRISPR-associated endonuclease (see the Perspective by van der Oost ). Cong et al. (p. 819 , published online 3 January) and Mali et al. (p. 823 , published online 3 January) adapted this defense system to function as a genome editing tool in eukaryotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upon target recognition, the DNA strands are opened in an R-loop and individually cleaved, which results in a double-strand break (DSB)22,23”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The technique also allows DNA sequence changes in pluripotent embryonic stem cells (4) that can then be cultured to produce specific tissues, such as cardiomyocytes or neurons (5).”
From A prudent path forward for genomic engineering and germline gene modification (2015) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In January 2013, almost simultaneously, five research articles authored by different research teams appeared, all reporting that they had achieved the goal.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mali et al. created a novel version of the genome-editing tool applicable to mammalian cells, termed the CRISPR/Cas9 system, which is based on modifications of the Streptococcus pyogenes type II CRISPR system in crRNA fused to trans-encoded tracrRNA 13 .”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“The pigs were engineered to carry 69 genomic edits, using the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9)-mediated nonhomologous end joining and homology-directed repair30,31, and recombinase-mediated cassette exchange32 (Fig. 2a, Extended Data Fig. 1a and Supplementary Table 2).”
From Design and testing of a humanized porcine donor for xenotransplantation (2023) · cites this paper as [31]
In the citing paper
“When a double-stranded break is introduced into genomic DNA, cells can repair the break by using a DNA molecule with high sequence similarity as a template. If an artificial template is provided while the DNA break is introduced, this pathway provides a mean to incorporate desired DNA sequences into the genome34,35”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [35]
In the citing paper
“The discovery, made less than 10 years ago, that a simple two-component system of a Cas protein (Streptococcus pyogenes Cas9) bound to a single guide RNA (sgRNA) can function as a programmable nuclease33 that can be deployed to cleave specific sequences in mammalian genomes34,35 has been transformative for biomedical research and the development of gene therapies.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [35]
In the citing paper
“Recently, the CRISPR/Cas system has been successfully applied to human cells19,20,21,22 and several model organisms for genome editing.23,24,25,26”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [19]
In the citing paper
“By bioinformatic screening and efficiency/off-target prediction (14, 15), we identified four gRNA targets (protospacers; LTRs A-D) that avoid conserved transcription factor binding sites, minimizing the likelihood of altering host gene expression”
From RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) · cites this paper as [15]
In the citing paper
“Compared with well-known, site-specific genome editing technologies, such as ZFNs and TALENs, the new CRISPR-Cas approach is more convenient and efficient [10], [12].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [10]
In the citing paper
“Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 is a naturally occurring bacterial immune system that uses a novel nuclease system to protect bacteria from phage infection (6-9), and it has recently been harnessed for a variety of genome-engineering applications (10)(11)(12)(13)(14)(15)(16)(17).”
From RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection (2014) · cites this paper as [13]
In the citing paper
“Moreover, no significant cytotoxicity was observed [87,88].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [88]
In the citing paper
“although Cas9 protein naturally induces double stranded DNA breaks by cutting each strand with two separate motifs, a mutation within one of the enzymatic motifs of Cas9 converted it into a valuable nickase with the capability to induce homologous recombination”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [88]
In the citing paper
“and the mutant is much safer to use with less off-target effects [88].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Lorenz, R., Bernhart, S. H., Höner zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F., & Hofacker, I. L. (2011) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-6-26 · Cited by 5,098
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295
Mathews, D. H., Sabina, J., Zuker, M., & Turner, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2700 · Cited by 3,795
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Cited by
Sorted by citations
Items 801–900 of 1,104
Rapidly evolving homing CRISPR barcodes
Kalhor, R., Mali, P., & Church, G. M. (2016) · Nature Methods · doi:10.1038/nmeth.4108 · Cited by 203
Self-citationChallenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors
Li, L., He, Z.-Y., Wei, X.-W., Gao, G.-P., & Wei, Y.-Q. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.069 · Cited by 202
Wang, W., Ye, C., Liu, J., Zhang, D., Kimata, J. T., & Zhou, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115987 · Cited by 202
Gene editing the phytoene desaturase alleles of Cavendish banana using CRISPR/Cas9
Naim, F., Dugdale, B., Kleidon, J., Brinin, A., Shand, K., Waterhouse, P. M., & Dale, J. L. (2018) · Transgenic Research · doi:10.1007/s11248-018-0083-0 · Cited by 202
Wahane, A. V., Waghmode, A., Kapphahn, A., Dhuri, K., Gupta, A., & Bahal, R. (2020) · Molecules · doi:10.3390/molecules25122866 · Cited by 202
Prime editing: advances and therapeutic applications
Zhao, Z., Shang, P., Mohanraju, P., & Geijsen, N. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.03.004 · Cited by 205
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Osborn, M. J., Webber, B. R., Knipping, F., Lonetree, C.-L., Tennis, N., DeFeo, A. P., McElroy, A. N., Starker, C. G., Lee, C., Merkel, S., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.197 · Cited by 201
Quantifying the contribution of recessive coding variation to developmental disorders
Martin, H. C., Jones, W. D., McIntyre, R., Sanchez-Andrade, G., Sanderson, M., Stephenson, J. D., Jones, C. P., Handsaker, J., Gallone, G., Bruntraeger, M., et al. (2018) · Science · doi:10.1126/science.aar6731 · Cited by 201
Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9
Anders, C., Bargsten, K., & Jinek, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.020 · Cited by 201
Huang, X., Wang, Y., Yan, W., Smith, C. J., Ye, Z., Wang, J., Gao, Y., Mendelsohn, L. G., & Cheng, L. (2015) · Stem Cells · doi:10.1002/stem.1969 · Cited by 201
Efficient oligo nucleotide mediated CRISPR-Cas9 gene editing in Aspergilli
Nødvig, C. S., Nielsen, J. B., Kogle, M. E., Jarczynska, Z. D., Lehmbeck, J. T., Klitgaard, D. K., & Mortensen, U. H. (2018) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2018.01.004 · Cited by 201
In vivo prime editing of a metabolic liver disease in mice
Böck, D., Rothgangl, T., Villiger, L., Schmidheini, L., Matsushita, M., Mathis, N., Ioannidi, E. I., Rimann, N., Grisch‐Chan, H. M., Kreutzer, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl9238 · Cited by 201
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Angulski, A. B. B., Hosny, N., Cohen, H., Martin, A. A., Hahn, D., Bauer, J., & Metzger, J. M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1183101 · Cited by 205
Moorthy, S. D., Davidson, S., Shchuka, V. M., Singh, G., Malek-Gilani, N., Langroudi, L., Martchenko, A., So, V., Macpherson, N. N., & Mitchell, J. A. (2016) · Genome Research · doi:10.1101/gr.210930.116 · Cited by 202
Genetic Approaches to Neural Circuits in the Mouse
Josh Huang, Z., & Zeng, H. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170307 · Cited by 200
TALEN-Mediated Gene Mutagenesis in Rhesus and Cynomolgus Monkeys
Liu, H., Chen, Y., Niu, Y., Zhang, K., Kang, Y., Ge, W., Liu, X., Zhao, E., Wang, C., Lin, S., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.018 · Cited by 200
Adenine base editing in an adult mouse model of tyrosinaemia
Song, C.-Q., Jiang, T., Richter, M., Rhym, L. H., Koblan, L. W., Zafra, M. P., Schatoff, E. M., Doman, J. L., Cao, Y., Dow, L. E., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0357-8 · Cited by 200
CRISPR-Cas9: a new and promising player in gene therapy
Xiao-Jie, L., Hui-Ying, X., Zun-Ping, K., Jin-Lian, C., & Li-Juan, J. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102968 · Cited by 200
Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
Gori, J. L., Hsu, P. D., Maeder, M. L., Shen, S., Welstead, G. G., & Bumcrot, D. A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.074 · Cited by 200
Gao, X., Tsang, J. C. H., Gaba, F., Wu, D., Lu, L., & Liu, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku836 · Cited by 200
Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG
Zhong, Z., Sretenovic, S., Ren, Q., Yang, L., Bao, Y., Qi, C., Yuan, M., He, Y., Liu, S., Liu, X., et al. (2019) · Molecular Plant · doi:10.1016/j.molp.2019.03.011 · Cited by 201
Self-citationCRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D. F. G., Clevers, H. C., & Artegiani, B. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.014 · Cited by 202
Jiang, X., Charlat, O., Zamponi, R., Yang, Y., & Cong, F. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.015 · Cited by 199
A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification
Chakraborty, S., Ji, H., Kabadi, A. M., Gersbach, C. A., Christoforou, N., & Leong, K. W. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.09.013 · Cited by 199
A generic strategy for CRISPR-Cas9-mediated gene tagging
Lackner, D. H., Carré, A., Guzzardo, P. M., Banning, C., Mangena, R., Henley, T., Oberndorfer, S., Gapp, B. V., Nijman, S. M. B., Brummelkamp, T. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms10237 · Cited by 199
Smith, J., Suresh, S., Schlecht, U., Wu, M., Wagih, O., Peltz, G., Davis, R. W., Steinmetz, L. M., Parts, L., & St.Onge, R. P. (2016) · Genome biology · doi:10.1186/s13059-016-0900-9 · Cited by 199
CRISPR/Cas9 editing genome of extremophile Halomonas spp.
Qin, Q., Chen, L., Zhao, Y., Yang, T., Yin, J., Guo, Y., & Chen, G. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.03.018 · Cited by 199
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Xu, C., Lu, Z.-D., Luo, Y., Liu, Y., Cao, Z., Shen, S., Li, H., Liu, J., Chen, K., Chen, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06522-5 · Cited by 199
Prediction of the sequence-specific cleavage activity of Cas9 variants
Kim, N., Kim, H. K., Lee, S., Seo, J. H., Choi, J. W., Park, J., Min, S., Yoon, S., Cho, S.-R., & Kim, H. H. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0537-9 · Cited by 198
Opportunities and challenges of pluripotent stem cell neurodegenerative disease models
Sandoe, J., & Eggan, K. C. (2013) · Nature Neuroscience · doi:10.1038/nn.3425 · Cited by 198
A chemical-inducible CRISPR–Cas9 system for rapid control of genome editing
Liu, K. I., Ramli, M. N., Woo, A., Wang, Y., Zhao, T., Zhang, X., Yim, D., Chong, B. Y., Ali, G., Chua, M. Z. H., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2179 · Cited by 199
Henriksson, J., Chen, X. X., Gomes, T., Ullah, U., Meyer, K. B., Miragaia, R. J., Duddy, G., Pramanik, J., Yusa, K., Lahesmaa, R., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.044 · Cited by 198
Use and application of 3D-organoid technology
Artegiani, B., & Clevers, H. C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy187 · Cited by 198
Engineering of high-precision base editors for site-specific single nucleotide replacement
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2019) · Nature Communications · doi:10.1038/s41467-018-08034-8 · Cited by 198
Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
Chen, F., Alphonse, M., & Liu, Q. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1609 · Cited by 197
CRISPaint allows modular base-specific gene tagging using a ligase-4-dependent mechanism
Schmid-Burgk, J. L., Höning, K., Ebert, T. S., & Hornung, V. (2016) · Nature Communications · doi:10.1038/ncomms12338 · Cited by 201
Ye, L., Wang, J., Tan, Y., Beyer, A. I., Xie, F., Muench, M. O., & Kan, Y. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612075113 · Cited by 197
Smith, I. C. P., Greenside, P., Natoli, T. E., Lahr, D. L., Wadden, D., Tirosh, I., Narayan, R., Root, D. E., Golub, T. R., Subramanian, A., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003213 · Cited by 197
CRISPR-Cas9-mediated homology-directed repair for precise gene editing
Liao, H., Wu, J., VanDusen, N. J., Li, Y., & Zheng, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102344 · Cited by 197
Zheng, M., Zhang, L. N., Tang, M., Liu, J., Liu, H., Yang, H., Fan, S., Terzaghi, W., Wang, H., & Hua, W. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13228 · Cited by 196
Ronda, C., Pedersen, L. E., Hansen, H. G., Kallehauge, T. B., Betenbaugh, M. J., Nielsen, A. T., & Kildegaard, H. F. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25233 · Cited by 195
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
Weber, J., Öllinger, R., Friedrich, M., Ehmer, U., Barenboim, M., Steiger, K., Heid, I., Mueller, S., Maresch, R., Engleitner, T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512392112 · Cited by 195
Activin/nodal signalling in stem cells
Pauklin, S., & Vallier, L. (2015) · Development · doi:10.1242/dev.091769 · Cited by 195
Darnell, A. M., Subramaniam, A. R., & O’Shea, E. K. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.041 · Cited by 195
Xu, W., Jin, T., Dai, Y., & Liu, C.-C. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112100 · Cited by 195
Base editors for simultaneous introduction of C-to-T and A-to-G mutations
Sakata, R. C., Ishiguro, S., Mori, H., Tanaka, M., Tatsuno, K., Ueda, H., Yamamoto, S., Seki, M., Masuyama, N., Nishida, K., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0509-0 · Cited by 197
Wei, T., Sun, Y., Cheng, Q., Chatterjee, S., Traylor, Z., Johnson, L. T., Coquelin, M. L., Wang, J., Torres, M. J., Lian, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42948-2 · Cited by 207
TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
Mussolino, C., Alzubi, J., Fine, E. J., Morbitzer, R., Cradick, T. J., Lahaye, T., Bao, G., & Cathomen, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku305 · Cited by 194
CRISPR/Cas9-mediated targeted chromosome elimination
Zuo, E., Huo, X., Yao, X., Hu, X., Sun, Y., Yin, J., He, B., Wang, X., Shi, L., Ping, J., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1354-4 · Cited by 194
Zhang, Q., Xing, H.-L., Wang, Z.-P., Zhang, H., Yang, F., Wang, X., & Chen, Q. (2018) · Plant Molecular Biology · doi:10.1007/s11103-018-0709-x · Cited by 195
CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
Song, R., Zhai, Q., Sun, L., Huang, E., Zhang, Y., Zhu, Y., Guo, Q., Tian, Y., Zhao, B., & Lu, H. X. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10007-w · Cited by 194
Genome Editing in Plants: Exploration of Technological Advancements and Challenges
Vats, S., Kumawat, S., Kumar, V., Patil, G., Joshi, T., Sonah, H., Sharma, T. R., & Deshmukh, R. K. (2019) · Cells · doi:10.3390/cells8111386 · Cited by 195
PrimeDesign software for rapid and simplified design of prime editing guide RNAs
Hsu, J. Y., Grünewald, J., Szalay, R. N., Shih, J., Anzalone, A. V., Lam, K. C., Shen, M. W., Petri, K., Liu, D. R., Joung, J. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21337-7 · Cited by 194
Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens
Haney, M. S., Bohlen, C. J., Morgens, D. W., Ousey, J. A., Barkal, A. A., Tsui, C. K., Ego, B. K., Levin, R., Kamber, R. A., Collins, H., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0254-1 · Cited by 193
Koonin, E. V., & Makarova, K. S. (2013) · RNA Biology · doi:10.4161/rna.24022 · Cited by 193
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
Ediriwickrema, A., & Saltzman, W. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab500084g · Cited by 193
Yang, T. T., Chong, W. M., Wang, W., Mazo, G., Tanos, B. E., Chen, Z., Tran, T. M. N., Chen, Y.-D., Weng, R. R., Huang, C.-E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04469-1 · Cited by 193
CRISPR Correction of Duchenne Muscular Dystrophy
Min, Y.-L., Bassel‐Duby, R., & Olson, E. N. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-010451 · Cited by 193
Zhu, L. J., Holmes, B. R., D, N. A. M., & Brodsky, M. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108424 · Cited by 192
Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9
Ceasar, S. A., Rajan, V., Prykhozhij, S. V., Berman, J. N., & Ignacimuthu, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.06.009 · Cited by 151
High-Level dCas9 Expression Induces Abnormal Cell Morphology in Escherichia coli
Cho, S., Choe, D., Lee, E., Kim, S. C., Palsson, B. Ø., & Cho, B. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00462 · Cited by 195
A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential
Zhou, H. Y., Katsman, Y., Dhaliwal, N. K., Davidson, S., Macpherson, N. N., Sakthidevi, M., Collura, F., & Mitchell, J. A. (2014) · Genes & Development · doi:10.1101/gad.248526.114 · Cited by 192
A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9
Carroll, K. J., Makarewich, C. A., McAnally, J., Anderson, D. M., Zentilin, L., Liu, N., Giacca, M., Bassel‐Duby, R., & Olson, E. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523918113 · Cited by 191
Precision genome editing in the CRISPR era
Salsman, J., & Dellaire, G. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0137 · Cited by 193
Ultraconserved Enhancers Are Required for Normal Development
Dickel, D. E., Ypsilanti, A. R., Pla, R., Zhu, Y., Barozzi, I., Mannion, B. J., Khin, Y. S., Fukuda-Yuzawa, Y., Plajzer-Frick, I., Pickle, C. S., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.017 · Cited by 190
ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway
Ho, L., Tan, S. Y. X., Wee, S., Wu, Y., Tan, S. J. C., Ramakrishna, N. B., Chng, S. C., Nama, S., Szczerbinska, I., Chan, Y.-S., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.08.010 · Cited by 192
Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function
Merkle, F. T., & Eggan, K. C. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.05.016 · Cited by 190
Wang, S., Sengel, C., Emerson, M. M., & Cepko, C. L. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.07.018 · Cited by 190
Šťovíček, V., Borodina, I., & Förster, J. (2015) · Metabolic Engineering Communications · doi:10.1016/j.meteno.2015.03.001 · Cited by 190
CRISPR transcriptional repression devices and layered circuits in mammalian cells
Kiani, S., Beal, J., Ebrahimkhani, M. R., Huh, J. H., Hall, R. N., Xie, Z., Li, Y., & Weiss, R. (2014) · Nature Methods · doi:10.1038/nmeth.2969 · Cited by 190
Targeted genome modification technologies and their applications in crop improvements
Chen, K., & Gao, C. (2013) · Plant Cell Reports · doi:10.1007/s00299-013-1539-6 · Cited by 190
Efficient programmable gene silencing by Cascade
Rath, D., Amlinger, L., Hoekzema, M., Devulapally, P. R., & Lundgren, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1257 · Cited by 190
Chen, B., Hu, J., Almeida, R., Liu, H., Balakrishnan, S., Covill‐Cooke, C., Lim, W. A., & Huang, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1533 · Cited by 190
Choi, I. Y., Lim, H., Estrellas, K. M., Mula, J., Cohen, T. V., Zhang, Y., Donnelly, C. J., Richard, J., Kim, Y. J., Kim, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.016 · Cited by 190
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
Mou, H., Smith, J. L., Peng, L., Yin, H., Moore, J. E., Zhang, X.-O., Song, C., Sheel, A., Wu, Q., Özata, D. M., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1237-8 · Cited by 190
Evolutionary dynamics of CRISPR gene drives
Noble, C., Olejarz, J. W., Esvelt, K. M., Church, G. M., & Nowak, M. A. (2017) · Science Advances · doi:10.1126/sciadv.1601964 · Cited by 190
Self-citationAccelerated homologous recombination and subsequent genome modification in Drosophila
Baena-López, L. A., Alexandre, C., Mitchell, A., Pasakarnis, L., & Vincent, J. (2013) · Development · doi:10.1242/dev.100933 · Cited by 189
Recent advances in the heterologous expression of microbial natural product biosynthetic pathways
Ongley, S. E., Bian, X., Neilan, B. A., & Müller, R. (2013) · Natural Product Reports · doi:10.1039/c3np70034h · Cited by 189
Chen, L., Li, W., Katin‐Grazzini, L., Ding, J., Gu, X., Li, Y., Gu, T., Wang, R., Lin, X., Deng, Z., et al. (2018) · Horticulture Research · doi:10.1038/s41438-018-0023-4 · Cited by 189
Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus
Hidalgo-Cantabrana, C., Goh, Y. J., Pan, M., Sanozky-Dawes, R., & Barrangou, R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905421116 · Cited by 189
Structural biology of CRISPR–Cas immunity and genome editing enzymes
Wang, J. Y., Pausch, P., & Doudna, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00739-4 · Cited by 191
Pflueger, C., Tan, D., Swain, T., Nguyen, T., Pflueger, J., Nefzger, C., Polo, J. M., Ford, E., & Lister, R. (2018) · Genome Research · doi:10.1101/gr.233049.117 · Cited by 188
Generation of muscular dystrophy model rats with a CRISPR/Cas system
Nakamura, K., Fujii, W., Tsuboi, M., Tanihata, J., Teramoto, N., Takeuchi, S., Naito, K., Yamanouchi, K., & Nishihara, M. (2014) · Scientific Reports · doi:10.1038/srep05635 · Cited by 188
Fast and sensitive detection of indels induced by precise gene targeting
Zhang, Y., Steentoft, C., Hauge, C., Hansen, L. H., Lind-Thomsen, A., Niola, F., Vester-Christensen, M. B., Frödin, M., Clausen, H., Wandall, H. H., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv126 · Cited by 188
Fujita, T., & Fujii, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.013 · Cited by 188
cGAS and Ifi204 Cooperate To Produce Type I IFNs in Response to Francisella Infection
Storek, K. M., Talmor, N., Ohlson, M. B., & Monack, D. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402764 · Cited by 188
Recent Progress in CRISPR/Cas9 Technology
Mei, Y., Wang, Y., Chen, H., Sun, Z. S., & Ju, X.-D. (2016) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.01.001 · Cited by 148
Lemos, B. R., Kaplan, A. C., Bae, J. E., Ferrazzoli, A. E., Kuo, J., Anand, R., Waterman, D. P., & Haber, J. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716855115 · Cited by 188
Development of CRISPR-Cas systems for genome editing and beyond
Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 188
Bothmer, A., Phadke, T., Barrera, L. A., Margulies, C. M., Lee, C. S., Buquicchio, F., Moss, S., Abdulkerim, H. S., Selleck, W., Jayaram, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms13905 · Cited by 187
Harnessing CRISPR–Cas systems for bacterial genome editing
Selle, K., & Barrangou, R. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.008 · Cited by 187
O’Hurley, G., Sjöstedt, E., Rahman, A., Li, B., Kampf, C., Pontén, F., Gallagher, W. M., & Lindskog, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.008 · Cited by 187
Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system
Gao, S., Tong, Y., Wen, Z., Zhu, L., Ge, M., Chen, D., Jiang, Y., & Yang, S. (2016) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-016-1789-8 · Cited by 187
CRISPR-SKIP: programmable gene splicing with single base editors
Gapinske, M., Luu, A., Winter, J., Woods, W. S., Kostan, K. A., Shiva, N., Song, J. S., & Pérez‐Piñera, P. (2018) · Genome biology · doi:10.1186/s13059-018-1482-5 · Cited by 191
Rasul, M. F., Hussen, B. M., Salihi, A. B., Ismael, B. S., Jalal, P. J., Zanichelli, A., Jamali, E., Baniahmad, A., Ghafouri‐Fard, S., Basiri, A., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01487-4 · Cited by 187
Pyne, M. E., Bruder, M. R., Moo‐Young, M., Chung, D. A., & Chou, C.-H. P. (2016) · Scientific Reports · doi:10.1038/srep25666 · Cited by 187
Hurwitz, S. N., Conlon, M. M., Rider, M. A., Brownstein, N. C., & Meckes, D. G. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.31295 · Cited by 186
CRISPR/Cas system for yeast genome engineering: advances and applications
Šťovíček, V., Holkenbrink, C., & Borodina, I. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox030 · Cited by 186
Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3′-overhang
Moon, S. B., Lee, J. M., Kang, J. G., Lee, N.-E., Ha, D.-I., Kim, D. Y., Kim, S. H., Yoo, K., Kim, J., Kim, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06129-w · Cited by 187
PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation
Mizuno, R., Sugiura, D., Shimizu, K., Maruhashi, T., Watada, M., Okazaki, I., & Okazaki, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00630 · Cited by 186
Metadata
- Authors
- Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M.
- Affiliations
- Harvard University (US)
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
- Boston University (US)
- Corresponding author
- Mali, Prashant
- Yang, Luhan
- Church, George M.
- Venue
- Science
- Published
- 2013-02-15
- Volume
- 339
- Issue
- 6121
- Pages
- 823-826
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3712628
- OpenAlex
- W2003171404
- Cited by
- 9,210
- References
- 46
- Citations by year
- 2026: 286 · 2025: 408 · 2024: 518 · 2023: 568 · 2022: 727 · 2021: 789 · 2020: 795 · 2019: 813 · 2018: 864 · 2017: 863 · 2016: 884 · 2015: 697 · 2014: 680 · 2013: 307
- FWCI
- 383.86
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Funders
- National Human Genome Research Institute (P50HG005550)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, guide RNA, human genome editing, AAVS1, multiplex genome editing, induced pluripotent stem cells, K562 cells, HEK293T cells, RNA-guided nucleases
- MeSH terms
- Chromosomes, Human, Pair 19, Codon, Exons, Genetic Engineering, Humans, RNA, Genome, Human, Gene Targeting, K562 Cells, DNA Cleavage, Inverted Repeat Sequences, Genetic Loci, Induced Pluripotent Stem Cells, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
